49 Wealth Management’s Inozyme Pharma INZY Stock Holding History

49 Wealth Management’s Portfolio INZY Stock Details INZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-40,675	Closed	-$163K	–	199
2025 Q2	$163K	Sell	40,675 -1,175	-3%	-$2.91K	0.02%	171
2025 Q1	$38.1K	Buy	+41,850	New	+$58K	﹤0.01%	186

49 Wealth Management's INZY Position: Q3 2025 in Review

49 Wealth Management sold out of Inozyme Pharma (INZY) in Q3 2025, closing a stake of 40,675 shares — an estimated $163K sold.

49 Wealth Management first reported a position in INZY in Q1 2025 and held it in 2 quarters. The position peaked at $163K in Q2 2025. 0 funds tracked by Wall St. Rank hold INZY as of Q3 2025.

49 Wealth Management reported no remaining Inozyme Pharma position as of Q3 2025 after selling out during the quarter.
49 Wealth Management sold 40,675 Inozyme Pharma shares in Q3 2025, an estimated $163K.
49 Wealth Management first reported a position in Inozyme Pharma in Q1 2025 and held it in 2 quarters.
49 Wealth Management's Inozyme Pharma position peaked at $163K in Q2 2025.
0 funds tracked by Wall St. Rank held Inozyme Pharma as of Q3 2025.

Based on 49 Wealth Management's 13F filing for Q3 2025, filed 12 Nov 2025.